CHF5993 and CHF1535 pMDI on Lung Hyperinflation and Exercise Endurance Time in Subjects With COPD

NCT05097014 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

106

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Obstructive Pulmonary Disease

Interventions

DRUG: CHF5993
DRUG: CHF1535
OTHER: Matched placebo

Sponsor

Chiesi Farmaceutici S.p.A.